Total Payments
$2,534
2024 Payments
$360.63
Companies
15
Transactions
128
Medicare Patients
111
Medicare Billing
$21,458
Payment Breakdown by Category
Food & Beverage$2,534 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,534 | 128 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $579.49 | 32 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $324.90 | 12 | $0 (2024) |
| ABBVIE INC. | $269.60 | 17 | $0 (2024) |
| Corium, LLC | $216.78 | 18 | $0 (2023) |
| Alkermes, Inc. | $196.96 | 8 | $0 (2024) |
| Lundbeck LLC | $167.32 | 9 | $0 (2024) |
| Novo Nordisk Inc | $146.28 | 2 | $0 (2022) |
| IRONSHORE PHARMACEUTICALS INC. | $146.20 | 7 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $112.70 | 1 | $0 (2022) |
| ITI, Inc. | $111.45 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.63 | 17 | Otsuka America Pharmaceutical, Inc. ($122.10) |
| 2023 | $887.98 | 53 | Otsuka America Pharmaceutical, Inc. ($195.23) |
| 2022 | $1,083 | 51 | Neurocrine Biosciences, Inc. ($237.49) |
| 2021 | $201.83 | 7 | Novo Nordisk Inc ($100.00) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: CNS | ||||||
| 05/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Neuropsychiatry | ||||||
| 05/01/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 04/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 02/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Central Nervous System | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: CNS | ||||||
| 11/16/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 66 | 169 | $26,481 | $11,045 |
| 2022 | 3 | 45 | 121 | $20,767 | $10,413 |
Total Patients
111
Total Services
290
Medicare Billing
$21,458
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 114 | $18,810 | $7,966 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,780 | $1,083 | 28.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 25 | $1,875 | $1,008 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 18 | $2,016 | $987.96 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 94 | $15,510 | $8,359 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 16 | $1,792 | $1,050 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,465 | $1,004 | 29.0% |
About Dr. Nigel Dsouza, M.D
Dr. Nigel Dsouza, M.D is a Psychiatry healthcare provider based in Mountain Home, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629504899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nigel Dsouza, M.D has received a total of $2,534 in payments from pharmaceutical and medical device companies, with $360.63 received in 2024. These payments were reported across 128 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,534).
As a Medicare-enrolled provider, Dsouza has provided services to 111 Medicare beneficiaries, totaling 290 services with total Medicare billing of $21,458. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Mountain Home, TN
- Active Since 05/10/2017
- Last Updated 11/03/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1629504899
Products in Payments
- REXULTI (Drug) $693.72
- INGREZZA (Drug) $324.90
- VRAYLAR (Drug) $269.60
- Azstarys (Drug) $170.85
- JORNAY PM (Drug) $146.20
- ARISTADA (Drug) $135.27
- Kerendia (Drug) $112.70
- CAPLYTA (Drug) $111.45
- RYBELSUS (Drug) $100.00
- TRINTELLIX (Drug) $90.05
- Auvelity (Drug) $62.24
- LYBALVI (Drug) $61.69
- Saxenda (Drug) $46.28
- AZSTARYS (Drug) $45.93
- Nuedexta (Drug) $42.79
- QELBREE (Drug) $36.99
- ABILIFY MYCITE (Drug) $29.32
- ABILIFY MAINTENA (Drug) $23.77
- Qelbree (Drug) $15.55
- Austedo XR (Drug) $14.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mountain Home
John Hendrick, M.d, M.D
Psychiatry — Payments: $2,063
Psychiatry $2,063
Veronica Zak, Md, MD
Psychiatry — Payments: $872.43
Psychiatry $872.43
Dr. Dan Nicolau, M.d, M.D
Psychiatry — Payments: $817.96
Psychiatry $817.96
Norman Moore, Md, MD
Psychiatry — Payments: $592.82
Psychiatry $592.82
Dr. Andrew Spitznas
Psychiatry — Payments: $67.63
Psychiatry $67.63
Dr. Thomas Olmsted, Md, MD
Psychiatry — Payments: $58.39
Psychiatry $58.39